3-O-sulfation of heparan sulfate as a regular of protein function
硫酸乙酰肝素的 3-O-硫酸化作为蛋白质功能的调节
基本信息
- 批准号:10615737
- 负责人:
- 金额:$ 45.17万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-05-01 至 2025-04-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAnticoagulantsBindingBinding ProteinsBiologicalBiological ProcessBiologyBlood Coagulation FactorBlood coagulationCarbohydratesCell AdhesionCell surfaceCellsChemicalsCodeCollectionComplement ActivationComplexDeep Vein ThrombosisDisaccharidesDiseaseEndothelial CellsEndotheliumEngineeringEnzymatic BiochemistryEnzymesEpitopesExtracellular MatrixGene FamilyGoalsGrowth FactorHeparinHeparitin SulfateHumanInfectionInflammationInflammatoryIsoenzymesLeadLibrariesLifeLigandsMalignant NeoplasmsMammalian CellMediatingMethodologyMethodsMicro Array DataModalityModificationNerve DegenerationOligosaccharidesPolysaccharidesPrintingProtein IsoformsProteinsPulmonary EmbolismRecombinantsSignal TransductionSignaling ProteinSiteSpecificityStructureStructure-Activity RelationshipSubstrate SpecificitySulfateSurfaceTechnologyTherapeuticThromboembolismVascular DiseasesVertebral columncell typechemokinecytokinegain of functionhuman diseaseinterestmast cellmorphogenspathogenpreventprogramsprotein functionrecruitsulfotransferasetherapeutic lead compound
项目摘要
Project summary/abstract
Heparin is a highly sulfated carbohydrate produced by mast cells that is widely used as an anticoagulant
to prevent deep vein thrombosis, pulmonary embolism and arterial thromboembolism. Heparan sulfate
(HS) is structurally related to heparin and decorates the surface of all most all human cells. It interacts
with a multitude of proteins including chemokines and cytokines; blood coagulation factors; growth
factors and morphogens, proteins involved in complement activation, and cell adhesion and signaling
proteins. HS has been implicated in human diseases such as vascular diseases, inflammation,
infections and neurodegeneration. It has been postulated that HS encodes information by an ability to
recruit proteins in a context-dependent manner. Although the “HS-sulfate code” hypothesis is
conceptually appealing, little is known about the ligand specificities of HS binding proteins and the
substrate specificities of HS-biosynthetic enzymes. As a result, it is not known whether isoforms of HS
biosynthetic enzymes can create distinctive epitopes that in a cellular context can recruit specific HS-
binding proteins. An understanding of the specificities of HS binding also offers opportunities to develop
therapeutic modalities.
In this program, chemical and chemo-enzymatic methodologies will be developed that will make it
possible to prepare a focused library of biologically relevant HS epitopes with and without a 3-O-sulfate
moiety. These compounds will be used to develop an HS-microarray to establish ligand requirement of
HS-binding proteins. Compounds of interest will be further explored for their ability to interfere in the
binding and cellular activation of endothelial cells. We will focus on HS-binding proteins involved in blood
coagulation, inflammation and vascular disease. The established structure-activity relationships are
expected to provide therapeutic lead compounds. The HS-microarray will also be used as a general
platform to discover and characterize HS-binding proteins requiring a 3-O-sulfate. In addition, the
synthetic compounds will be used to define substrate requirements of the various 3-O-sulfotransferases.
Collectively, our studies will address the question of whether isoforms of 3-O-sulfotransferases can
create distinctive epitopes that can recruit specific HS-binding proteins, to mediate various biological
processes.
1
项目摘要/摘要
肝素是由肥大细胞产生的高度硫酸盐,被广泛用作抗凝剂
硫酸乙酰肝素可预防深静脉血栓形成,肺栓塞和动脉血栓主义。
(HS)在结构上与肝素相关,并装饰了所有大多数人类细胞的表面。它相互作用
具有多种蛋白质,包括趋化因子和细胞因子;血液凝血因子;生长
因子和形态剂,涉及完成激活的蛋白质以及细胞粘合剂和信号传导
蛋白质。 HS已在人类疾病中浸渍,例如血管疾病,炎症,
感染和神经变性。有人认为,HS通过能力编码信息
以上下文的方式募集蛋白质。尽管“ HS硫酸盐代码”假设是
从概念上看,关于HS结合蛋白的配体规范和
HS生物合成酶的底物规范。结果,尚不清楚HS的同工型是否
生物合成酶可以产生独特的表位,在细胞环境中可以募集特定的HS-
结合蛋白。对HS约束的特异性的理解也为发展提供了机会
治疗方式。
在该计划中,将开发化学和化学酶方法,以使其成为
有可能,有或没有3-O硫酸盐的生物学相关的HS表位图书馆
部分。这些化合物将用于开发HS微阶层,以建立配体要求
HS结合蛋白。感兴趣的化合物将进一步探讨其干扰能力
内皮细胞的结合和细胞活化。我们将专注于血液中涉及的HS结合蛋白
凝血,感染和血管疾病。建立的结构活动关系是
预计提供热铅化合物。 HS微阵列也将用作一般
发现和表征需要3-O硫酸盐的HS结合蛋白的平台。另外,
合成化合物将用于定义各种3-O-硫代转移酶的底物需求。
总的来说,我们的研究将解决3-O-硫代转移酶的同工型的问题
创建独特的表位,可以募集特定的HS结合蛋白,以培养各种生物学
过程。
1
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Geert-Jan Boons其他文献
Geert-Jan Boons的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Geert-Jan Boons', 18)}}的其他基金
Automated chemo-enzymatic synthesis of N-glycans for host-pathogen interactions
用于宿主-病原体相互作用的 N-聚糖自动化学酶合成
- 批准号:
10626153 - 财政年份:2022
- 资助金额:
$ 45.17万 - 项目类别:
Automated chemo-enzymatic synthesis of N-glycans for host-pathogen interactions
用于宿主-病原体相互作用的 N-聚糖自动化学酶合成
- 批准号:
10521604 - 财政年份:2022
- 资助金额:
$ 45.17万 - 项目类别:
Synthetic multi-component influenza vaccines to elicit broad immunity
合成多成分流感疫苗可引发广泛免疫力
- 批准号:
10458316 - 财政年份:2021
- 资助金额:
$ 45.17万 - 项目类别:
3-O-sulfation of heparan sulfate as a regular of protein function
硫酸乙酰肝素的 3-O-硫酸化作为蛋白质功能的调节
- 批准号:
10400697 - 财政年份:2020
- 资助金额:
$ 45.17万 - 项目类别:
Streamlining the chemoenzymatic synthesis of asymmetrical glycans of biological importance
简化具有生物学重要性的不对称聚糖的化学酶合成
- 批准号:
9752086 - 财政年份:2016
- 资助金额:
$ 45.17万 - 项目类别:
Streamlining the chemoenzymatic synthesis of asymmetrical glycans of biological importance
简化具有生物学重要性的不对称聚糖的化学酶合成
- 批准号:
9533657 - 财政年份:2016
- 资助金额:
$ 45.17万 - 项目类别:
Streamlining the chemoenzymatic synthesis of asymmetrical glycans of biological importance
简化具有生物学重要性的不对称聚糖的化学酶合成
- 批准号:
9749989 - 财政年份:2016
- 资助金额:
$ 45.17万 - 项目类别:
Streamlining the chemoenzymatic synthesis of asymmetrical glycans of biological importance
简化具有生物学重要性的不对称聚糖的化学酶合成
- 批准号:
9166183 - 财政年份:2016
- 资助金额:
$ 45.17万 - 项目类别:
Mammalian Glycosyltransferases for use in Chemistry and Biology
用于化学和生物学的哺乳动物糖基转移酶
- 批准号:
8874755 - 财政年份:2013
- 资助金额:
$ 45.17万 - 项目类别:
Mammalian Glycosyltransferases for use in Chemistry and Biology
用于化学和生物学的哺乳动物糖基转移酶
- 批准号:
8740506 - 财政年份:2013
- 资助金额:
$ 45.17万 - 项目类别:
相似国自然基金
类血友病机制的凝胶微球抗凝剂的研究
- 批准号:
- 批准年份:2020
- 资助金额:58 万元
- 项目类别:面上项目
凝血因子XI多肽抑制剂的开发及抗血栓作用研究
- 批准号:21708043
- 批准年份:2017
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
新型抗凝剂枸橼酸双乙酯代谢过程、抗凝机制与钙转运关系
- 批准号:30871164
- 批准年份:2008
- 资助金额:29.0 万元
- 项目类别:面上项目
相似海外基金
Targeting HNF4-induced thrombo-inflammation in Chagas disease
针对恰加斯病中 HNF4 诱导的血栓炎症
- 批准号:
10727268 - 财政年份:2023
- 资助金额:
$ 45.17万 - 项目类别:
Tele-Sox: A Tele-Medicine solution based on wearables and gamification to prevent Venous thromboembolism in Oncology Geriatric Patients
Tele-Sox:基于可穿戴设备和游戏化的远程医疗解决方案,用于预防肿瘤老年患者的静脉血栓栓塞
- 批准号:
10547300 - 财政年份:2023
- 资助金额:
$ 45.17万 - 项目类别:
Contact Pathway Inhibitor to Prevent Vascular Access Failure
接触途径抑制剂以防止血管通路失败
- 批准号:
10604057 - 财政年份:2023
- 资助金额:
$ 45.17万 - 项目类别:
Development of an RNA-based anticoagulant and antidote for precise on/off coagulation control during cardiovascular procedures
开发基于 RNA 的抗凝剂和解毒剂,用于心血管手术期间精确的开/关凝血控制
- 批准号:
10603072 - 财政年份:2023
- 资助金额:
$ 45.17万 - 项目类别:
The Transmembrane Protein Disulfide Isomerase TMX1 Negatively Regulates Thrombosis
跨膜蛋白二硫键异构酶 TMX1 负向调节血栓形成
- 批准号:
10586515 - 财政年份:2023
- 资助金额:
$ 45.17万 - 项目类别: